Avenzoar Pharmaceuticals

Avenzoar Pharmaceuticals

Pioneering small molecule therapeutics targeting cancer metastasis and drug resistance. AI-enabled precision oncology for recalcitrant cancers.

Private Company

Total funding raised: $165M

About

Pioneering small molecule therapeutics targeting cancer metastasis and drug resistance. AI-enabled precision oncology for recalcitrant cancers.

Small Molecules

Funding History

2
Total raised:$165M
Series A$150M
Seed$15M